Historical record - last NADAC effective date: 4/22/2015
Product Information
TINIDAZOLE 250 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $2.3575 per EA under NDC 43386055004. Its NADAC has been published 121 times since Jan 22, 2014.
FDA first approved this application on Apr 30, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386055004
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/22/2015
Active Ingredients
TINIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA202044FDA Approved
4/30/2012
TE Code
AB
On Market Since
4/30/2012
Pharmacological Classes
Price Statistics
The NADAC for TINIDAZOLE 250 MG TABLET has been published 121 times since Jan 22, 2014, and over the history we have for it it has declined 28.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3575 per EA |
|---|---|
| All-time high | $3.2986 (Feb 12, 2014) |
| All-time low | $2.3131 (Feb 19, 2014) |
| Median price | $2.9598 |
| Average price | $2.6709 |
| Largest weekly change | -29.9% (Feb 19, 2014) |
| Weeks tracked | 121 |
| Tracking since | Jan 22, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-28.5%
Last surveyed May 11, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tinidazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitroimidazole Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TINIDAZOLE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TINIDAZOLE 250 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $2.3575 per EA (NDC 43386055004), effective May 11, 2016.
How has the price of TINIDAZOLE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for TINIDAZOLE 250 MG TABLET has declined 28.5%. It has been tracked across 121 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for TINIDAZOLE 250 MG TABLET?
Since Jan 22, 2014, the NADAC for TINIDAZOLE 250 MG TABLET has ranged from a low of $2.3131 (Feb 19, 2014) to a high of $3.2986 (Feb 12, 2014), with a median of $2.9598 per EA.
Are there cheaper alternatives to TINIDAZOLE 250 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TINIDAZOLE 250 MG TABLET, is $1.5032 per EA — about 36% below TINIDAZOLE 250 MG TABLET.
Who manufactures TINIDAZOLE 250 MG TABLET?
TINIDAZOLE 250 MG TABLET (NDC 43386055004) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.